Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/2003
10/09/2003CA2480633A1 Neurotrophic and neuroprotective peptides
10/09/2003CA2480164A1 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents
10/09/2003CA2479939A1 Immunosuppressant compounds, methods and uses related thereto
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
10/08/2003EP1349829A2 Catalyst modification to enhance neotame production
10/07/2003US6630513 Capable of lowering plasma cholesterol levels and inhibiting abnormal cell proliferation, such as in cervical adenocarcinoma
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630487 Treatment of insulin resistance with growth hormone secretagogues
10/07/2003US6630451 Benzimidazolone peptidometics as thrombin receptor antagonist
10/07/2003US6630191 Such as N-(N-(3-(3-hydroxy-4-methoxyphenyl)propyl)-L-alpha-aspartyl)-L -(alphamethyl)phenylalanine-1-methyl ester; stability; safety
10/02/2003WO2003080662A1 Protein kinase c modulators, their aminoacid and nucleotide sequences and uses thereof
10/02/2003WO2003080611A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
10/02/2003WO2003080602A1 Maleic acid salt of (2s)-n-{5-[amino(imino)methyl]-2-thienyl}methyl-1-{(2r)-2-[(carboxymethyl)amino]3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for
10/02/2003WO2003080601A1 New crystalline forms of (2s)-n-5-[amino(imino)methyl]-2-thienylmethyl-1-(2r)-2-[(carboxymethyl)amino]-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
10/02/2003WO2003051910A3 Inhibitors of hepatitis c virus protease
10/02/2003WO2003050139A3 Prion inhibiting peptides and derivatives thereof
10/02/2003US20030187188 Synthesis of peptoid substituted azole compounds
10/02/2003US20030187186 Glycopeptide and preparation thereof
10/02/2003US20030187018 Viricides; immunomoderators
10/02/2003US20030186896 Crystalline form of perindopril tert-butylamine salt
10/02/2003US20030186895 Peptide mimetics used as RNA virus protease inhibitors, for prophylaxis of hepatitis virus infections
10/02/2003US20030186877 Helical peptidomimetics
10/02/2003US20030186874 Genetic enhancers comprising amino acid sequences derived from retrovirus envelope proteins coupled to core peptides, used as drugs having improve half life
10/02/2003US20030186863 For production of peptidomimetic drugs that modulate a large class of proteins involved in signal transduction pathways and oncogenesis
10/02/2003US20030186844 Gherlin analogs
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186388 Method of producing fr901228
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186214 Peptide conjugates and fluorescence detection methods for intracellular caspase assay
10/02/2003US20030185793 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same
10/02/2003CA2480039A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/02/2003CA2479893A1 Maleic acid salt of (2s)-n-{5-¬amino(imino)methyl|-2-thienyl}methyl-1-{(2r)-2-¬(carboxymethyl)amino|3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for preparing the same
10/02/2003CA2479888A1 New crystalline forms of (2s)-n-5-¬amino(imino)methyl|-2-thienylmethyl-1-(2r)-2-¬(carboxymethyl)amino|-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
10/01/2003EP1348460A2 Creating an aerosolized formulation of insulin
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347989A1 Bile-acid conjugates for providing sustained systemic concentrations of drugs
10/01/2003EP1347953A2 Agents and methods for promoting bone growth
10/01/2003EP1347784A2 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
10/01/2003EP1019434B1 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446201A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/01/2003CN1446101A Combination product comprising melagatran and factor VLLa inhibitor
10/01/2003CN1446098A Modulation of alpha-6 integrin-mediated responses
09/2003
09/30/2003US6627769 Antiproliferative agents
09/30/2003US6627732 Enhanced hematopoiesis promoting effect
09/30/2003US6627431 Hydrolyzing the ester using a lipase from Pseudomonas and esterase from porcine liver; use as artificial sweetener
09/30/2003CA2102697C Pyrrolidine derivatives, preparation thereof and drugs containing same
09/25/2003WO2003079403A2 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
09/25/2003WO2003079022A1 Ffluorescent reagent for selectively detecting double-stranded nucleic acid contianing fluorescent dye group and intercalate group
09/25/2003WO2003079010A1 Fluorescent reagent cotanining fluorescent intercalator groups for detecting double-stranded nucleic acid
09/25/2003WO2003078383A1 Novel positively charged lipids and liposomes comprising the positively charged lipids
09/25/2003WO2003077928A1 Peptide analogues and uses thereof
09/25/2003WO2003006489A3 Prodrugs of excitatory amino acids
09/25/2003WO2002015922A3 New uses for amino acid anticonvulsants for treatment of pain
09/25/2003US20030181391 Dipeptide apoptosis inhibitors and the use thereof
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003US20030181388 Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or entire
09/25/2003US20030181363 Compounds or pharmaceutically acceptable salt thereof, useful as inhibitors of the HCV NS3 protease.
09/25/2003US20030181359 Tripeptide prodrug compounds
09/25/2003US20030180805 Methods and compositions for derepression of IAP-inhibited caspase
09/25/2003US20030180734 Peptide nucleic acids
09/25/2003US20030180729 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents
09/25/2003US20030180222 Using paramagnetic chelate peptide compound
09/25/2003CA2459836A1 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
09/24/2003EP1346041A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
09/24/2003EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences
09/24/2003EP1345955A2 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release
09/24/2003EP1345918A1 Chemical compounds
09/24/2003EP1036061B1 New compounds
09/24/2003EP0785713B1 Creating an aerosolized formulation of insulin
09/23/2003US6624288 Conotoxins comprising cyclic peptides used as agonists of calcium channels blockers
09/23/2003US6624147 Inhibitors of prenylated pyrophosphate consuming enzymes
09/23/2003CA2218555C Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
09/18/2003WO2003076944A1 Annotation of genome sequences
09/18/2003WO2003076458A2 Selective dipeptide inhibitors of kallikrein
09/18/2003WO2003076457A1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME
09/18/2003WO2003076391A2 Urokinase inhibitors, production and use thereof
09/18/2003WO2003051848A3 Imidazolidineacetic acid derivatives
09/18/2003WO2003039454A8 Beta-secretase inhibitors and methods of use
09/18/2003WO2002102764A3 Method for producing chiral amino acid derivatives
09/18/2003WO2001072956A3 Compounds and methods for modulating desmosomal cadherin-mediated functions
09/18/2003US20030176689 Inhibitors of hepatitis C virus protease
09/18/2003US20030176643 Which function as motilin receptor antagonists; gastrointestinal motility suppressors
09/18/2003US20030176642 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
09/18/2003US20030176398 Prodrugs of GABA analogs, compositions and uses thereof
09/18/2003US20030176361 Having cytoprotective activity and protective activity for neuroinflammation, and neurodegenerative disorders; for use in therapy of stroke, cerebral ischemia, myocardial infarction, myocardial ischemia, chronic heart failure, inflammation
09/18/2003US20030176354 Therapeutic uses of tri-, tetra-, penta-, and polypeptides
09/18/2003US20030176329 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
09/18/2003US20030175745 Peptides with growth inhibitory action
09/18/2003US20030175276 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents
09/18/2003CA2478412A1 Inhibitors of the blood-clotting factor xa, production thereof and use of the same
09/17/2003EP1344773A1 Growth hormone secretagogues
09/17/2003EP1343810A2 Diaminodicarboxylic acid: peptide-based gemini surfactant compounds used for drug delivery
09/17/2003EP1343807A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
09/17/2003EP1343805A1 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
09/17/2003EP1343516A2 Analogues of thiocoraline and be-22179
09/17/2003EP1230260B1 Hcv ns3 protease inhibitors
09/17/2003CN1443351A Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition
09/17/2003CN1443198A Ghrelin拮抗剂 Ghrelin Antagonist
09/17/2003CN1443079A Polymeric conjugates of antitumor agents
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 307